| Source: |
| Type: |
| Cellular senescence is a state in which cells cease to divide and grow, often in response to DNA damage or other forms of cellular stress. On one hand, senescence can prevent cancer by: -Halting the proliferation of damaged cells, thereby preventing the accumulation of mutations that can lead to cancer -Activating immune responses that can eliminate senescent cells. -Producing anti-tumor factors that can inhibit the growth of nearby cancer cells. On the other hand, senescence can also promote cancer by: -Creating a pro-tumorigenic microenvironment that can support the growth of nearby cancer cells -Producing pro-inflammatory factors that can promote cancer progression -Contributing to the development of a senescence-associated secretory phenotype (SASP), which can promote cancer cell growth and metastasis. |
| 6920- | FIS, | A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design |
| - | Trial, | BC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:920 State#:% Dir#:0
wNotes=0 sortOrder:rid,rpid